Prenetics Global (PRE) Sidoti's Year End Virtual Investor Conference summary

Business overview and growth trajectory

• Transitioned from diagnostics to consumer healthcare, now focused on IM8, a premium supplement brand co-founded with David Beckham.

• Achieved $100 million ARR for IM8 in 11 months, with projected 2025 revenue of $180-$200 million and $350-$400 million by 2027.

• IM8 is sold in 41 countries, 100% direct-to-consumer, with 80% subscription rate and $145 average order value.

• Company holds $70 million in cash, 510 BTC, and a 35% stake in Insighta valued at $70 million.

• Total net asset value is approximately $560 million, with IM8 business conservatively valued at $380 million.

Product strategy and innovation

• IM8's hero product, Daily Ultimate Essentials, replaces 16 supplements in a single powdered drink.

• Launched a second SKU, Daily Ultimate Longevity, increasing average order value by 35%.

• Plans to launch 2-3 new SKUs annually, each NSF Certified for Sport and third-party tested.

• Focus on simplicity and quality, not mass SKU proliferation.

• High-profile ambassadors include Aryna Sabalenka, with more planned.

Financial performance and profitability

• Quarterly losses reduced from $6.5 million in Q1 to $2.1 million in Q3 while maintaining rapid growth.

• High recurring revenue base allows for potential profitability if growth investment is paused.

• Payback period for customer acquisition is 3.9 months, outperforming industry peers.

• Zero debt and strong cash position provide operational flexibility.